Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug Application of Epimedin C in Treating Diabetic Liver Injury

A technology of diabetes and epimedin, which is applied in the application field of preparing drugs for the treatment of diabetic liver damage, and can solve the problem of not fully considering the taste and bioavailability of drugs, and it is difficult to reveal the substances of Epimedium used in the treatment of diabetes and its complications Fundamental and other issues to achieve the effect of improving liver oxidative stress, alleviating lipid metabolism disorders, and increasing HDL-C levels

Active Publication Date: 2021-02-12
陕西新修本草健康产业有限公司
View PDF10 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] (1) In most existing technologies, Epimedium is combined with other medicinal materials to make Chinese patent medicines or traditional Chinese medicine compound preparations for the prevention and treatment of diabetes and its complications. No single use of Epimedium, Epimedium extract or Epimedium Report on the Treatment of Diabetes Mellitus and Its Complications by Flavonoids Monomers of Goatwort
[0009] (2) Most of the existing technologies use Epimedium or its extracts for the prevention and treatment of diseases such as diabetes and osteoporosis, and there are few reports on the use of Epimedium or its extracts in the treatment of diabetic liver injury complications
[0010] (3) In some prior art, the total flavonoids of Epimedium or Epimedium extract are combined with other traditional Chinese medicine extracts for the prevention and treatment of diabetes and its complications, but there is no single flavonoid compound Epimedin C Any relevant reports on the use of body in the treatment of diabetes mellitus and its complications
It is difficult to reveal the material basis of epimedium used in the treatment of diabetes and its complications in the prior art, so it shows that there is no report on the effect of epimedin C in the treatment of diabetic liver injury in the prior art
[0011] (4) Most of the existing technologies do not fully consider the taste and bioavailability of drugs when preparing pharmaceutical preparations containing Epimedium medicinal materials, total flavonoids or extracts
But so far there is no report about the effect of Epimedin C on treating diabetic liver damage and its use in the preparation of drugs for treating diabetic liver damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug Application of Epimedin C in Treating Diabetic Liver Injury
  • Drug Application of Epimedin C in Treating Diabetic Liver Injury
  • Drug Application of Epimedin C in Treating Diabetic Liver Injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1: the preparation of epimedin C buccal tablet

[0042] A buccal tablet of Epimedin C for treating diabetic liver damage, its prescription is made of the following components by mass percentage: Epimedin C is 65%, arabinose is 9.8%, steviol glycoside is 0.1%, microcrystalline fiber 15% sodium cellulose, 9% hypromellose, 1% magnesium stearate, and 0.1% absolute ethanol.

[0043] The preparation method of Epimedin C buccal tablet is:

[0044] Step 1, weighing and pretreatment of raw materials: Weigh epimedin C, arabinose, steviol glycoside, microcrystalline cellulose, hypromellose and magnesium stearate respectively according to predetermined mass percentages, and pass through a 60-mesh sieve.

[0045] Step 2, making soft material: take Epimedin C, add arabinose and steviol glycoside, use absolute ethanol as wetting agent, stir well, add microcrystalline cellulose and hypromellose, stir well, and make soft material material.

[0046] Step 3, granulation: Put...

Embodiment 2

[0049] Embodiment 2: the preparation of epimedin C coated tablet

[0050] A kind of Epimedin C coated tablet for treating diabetic liver damage, its prescription is made of the following components by mass percentage: Epimedin C is 49.8%, microcrystalline cellulose is 15%, magnesium stearate is 1% , hypromellose 5%, steviol glycoside 0.2%, glycerin 1%, talc 1%, distilled water 27%.

[0051] The preparation method of Epimedin C coated tablet is:

[0052] Step 1, weighing and pretreatment of raw materials: Weigh the Epimedin C, microcrystalline cellulose, magnesium stearate and hypromellose respectively according to the predetermined mass percentage, and pass through a 60-mesh sieve.

[0053] Step 2, preparation of tablet cores: Take Epimedin C, add microcrystalline cellulose and hypromellose, mix well, use distilled water as a binder to make a soft material, and then put the wet granules into 60°C and blow dry Dry it in the box for about 1 hour, sprinkle magnesium stearate an...

Embodiment 3

[0056] Embodiment 3: the preparation of epimedin C hard capsule

[0057] An epimedin C capsule for treating diabetic liver damage, the prescription of which is made of the following components by mass percentage: epimedin C is 70%, and dietary fiber is 30%. In addition, several pharmaceutical gelatin hard capsule shells are required.

[0058] The preparation method of Epimedin C hard capsule is:

[0059] Step 1, raw material weighing and pretreatment: Weigh Epimedin C and dietary fiber respectively according to the predetermined mass percentage, and pass through a 60-mesh sieve.

[0060] Step 2, preparation of the filling material: mix the Epimedin C and the dietary fiber evenly.

[0061] Step 3, filling the capsule: using the free flow method to make the filling material enter the capsule shell, and then close the capsule cap to obtain the Epimedin C hard capsule.

[0062] Further illustrate the therapeutic effect of Epimedin C of the present invention on diabetic liver in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the drug application of epimedin C for treating diabetic liver injury, and belongs to the technical field of biomedicine. The present invention discloses for the first time that epimedin C can increase the level of high-density lipoprotein cholesterol in the liver of diabetic model animals, reduce the level of low-density lipoprotein cholesterol in the liver, alleviate the problem of lipid metabolism disorder, reduce liver index, and enhance superoxide dismutase in the liver , Glutathione peroxidase activity, reduce malondialdehyde content, improve liver oxidative stress state, maintain normal shape and structure of liver cells and tissues, reduce liver alanine aminotransferase and aspartate aminotransferase activity levels, and promote liver function repair, Therefore, it can be used to prepare medicines for treating diabetic liver damage. Epimedin C prepares a medicine for treating diabetic liver damage and uses it in the form of pharmaceutical preparations, including buccal tablets, coated tablets and hard capsules. The invention provides a basis for the treatment of diabetic liver damage, and also provides ideas for the deep development and utilization of epimedium resources.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and relates to the new effect of Epimedin C in treating complications of diabetic liver damage (abbreviated as diabetic liver damage), and its application in the preparation of drugs for treating diabetic liver damage. Background technique [0002] In recent years, the incidence of diabetes has increased year by year, and it has become the third major disease that seriously endangers human life and health after cardiovascular and cerebrovascular diseases and tumors. Diabetic complications are an important cause of disability and death in patients. As an important organ of sugar and lipid metabolism, the liver has a very close relationship with diabetes. Diabetes may cause damage to the liver in many ways, leading to complications of liver damage. Due to the atypical clinical symptoms of diabetic liver injury and other reasons, it has not been paid much attention by the medical community in ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/352A61P1/16A61P3/10A61K9/20A61K47/26A61K9/36A61K9/48A61K47/36
CPCA61K9/0056A61K9/2018A61K9/2826A61K9/4866A61K31/352A61P1/16A61P3/10
Inventor 张华峰周雪雪杨晓华薛梦莹
Owner 陕西新修本草健康产业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com